Elkind-Hirsch KE, Chappell N, Shaler D, Storment J, Bellanger D (2022) Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
Blue Cross Blue Shield of Michigan will pull back on coverage for GLP-1 drugs amid rising costs for these products
The number of injections you need and the dosage level both influence your overall treatment cost
Many patients prefer injecting on Sunday or Monday mornings, which fits naturally into their weekly routine
Ensuring that those who need Retatrutide can afford it will be a significant challenge
Participants who experienced plateau sensations were typically those who remained at static doses rather than escalating during the titration phase